
Moleculin Biotech, Inc. (MBRX) stock is popping high today. What’s going on?
Moleculin Biotech, Inc. (MBRX) received the approval of Fast Track Designation for Annamycin by the FDA after which the MBRX stock happened to be green
Home » MBRX
Moleculin Biotech, Inc. (MBRX) received the approval of Fast Track Designation for Annamycin by the FDA after which the MBRX stock happened to be green
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Moleculin Biotech, Inc., (Nasdaq: MBRX) surged 43.59% in the pre-market session after, a clinical-stage pharmaceutical corporation with a wide pipeline of drug candidates targeting highly
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.